June 17, 2015—Almost three-quarters of Americans think the cost of prescription drugs is unreasonable, according to a new tracking poll from the Kaiser Family Foundation. About half feel there isn’t enough government regulation limiting the price of medicines. … [Read more...]
HHS Releases 340B Manufacturer Civil Monetary Penalty Proposed Rule
Regulation also clarifies calculation of 340B ceiling pricesJune 16, 2015—A proposed federal regulation implementing financial sanctions for drugmakers for overcharging 340B covered entities is due to be published in the Federal Register tomorrow. … [Read more...]
MedPAC Report Touches on 340B
Commission discusses reducing hospital reimbursement but makes no recommendationsJune 16, 2015—If policymakers were to decide to reduce Medicare payments for Part B drugs bought by 340B hospitals, they may want to let those hospitals keep a share of their 340B savings as an incentive to stay in the program, congressional Medicare policy advisers say in a new report. … [Read more...]
HIV/AIDS Activists Protest at 340B Summit
"They need to make sure they're including organizations that actually use the 340B program"June 12, 2015—About a dozen HIV/AIDS activists demonstrated yesterday on the sidewalk outside the downtown Washington government building where the second National Leadership Summit on 340B was held. The meeting was organized by the Alliance for Integrity and Reform of 340B, a drug industry-led group that believes the 340B program needs major reform. AIDS Healthcare Foundation, … [Read more...]
Congresswoman Addresses AIR 340B Summit
Says she looks forward to HRSA's omnibus guidance and input from stakeholdersJune 11, 2015—A member of the House Energy & Commerce Committee said at a drug industry organized "summit" today she hopes that forthcoming 340B program omnibus guidance can be the basis for an "ongoing conversation among stakeholders" about the drug pricing program's future. … [Read more...]
340B Drugmaker Monetary Penalties Rule Cleared for Publication
White House budget office completed its review on June 5June 8, 2015—The White House Office of Management and Budget has finished reviewing a proposed 340B program regulation to impose civil monetary sanctions on drugmakers that intentionally overcharge safety-net healthcare providers for 340B-discounted drugs. … [Read more...]
Study: Medicaid Expansion Isn’t Miracle Cure for Public, Nonprofit Hospitals
Reductions in bad debt aren't necessarily translating into better financialsJune 5, 2015—Medicaid expansion hasn't been the quick pick-me-up for public and nonprofit hospitals' finances as some expected, a new report by Moody's Investors Service concludes. … [Read more...]